Report      Database

    United States - Liquid Biopsy Potential Testing Market & Volume Analysis to 2020

    Date: 12 Jan, 2016              Type: Diagnostics              Pages: 79

    United States - Liquid Biopsy Potential Testing Market & Volume Analysis to 2020
    • Electronic Access - Single User License
      $900.00
    • CD-ROM Mail Delivery
      $1,000.00
    • Hard-copy Mail Delivery
      $1,000.00
    • Electronic Access - Multi User License
      $1,400.00

     

    United States – Liquid Biopsy Testing Market - Overview

    Liquid Biopsy Tests are emerging as a viable alternative to traditional methods for cancer screening. A liquid biopsy is a new type of blood test that has the potential to transform cancer treatment. Using this methodology, physicians avoid the traditional surgical and needle biopsies they use to determine the existence of cancer in patients. In United States Liquid Biopsy market; Screening Test is likely to capture major chunk of the market compared to Monitoring Market. It is anticipated that Liquid Biopsy Testing will be more helpful for monitoring cancer treatment and status after diagnosis than in screening for a cancer that may be years or even decades in the making and not otherwise detectable.

     

    United States – Liquid Biopsy Potential Screening Market Analysis: In the United States liquid biopsy screening market, prostate cancer is the most popular segment. Lung cancer liquid biopsy screening stands at the last spot.

     

    United States – Liquid Biopsy Potential Treatment Monitoring Market Analysis: In the United States liquid biopsy treatment monitoring market, breast cancer is the leading segment. Liver cancer stands at the fifth spot.

     

    Renub Research report titled United States – Liquid Biopsy Potential Testing Market & Volume Analysis to 2020 provides a comprehensive assessment of the fast–evolving, high–growth of Liquid Biopsy Market. This 79 page report with 41 Figures analyses the United States Liquid Biopsy Test Market and Volume by 5 Top Cancer Segment, Recent developments, Major Deals along with the driving factors and challenges for Liquid Biopsy Market.

     

    The United States Liquid Biopsy Potential Market has been analyzed from two view points

     

    1. United States Liquid Biopsy Potential Screening Market & Test Volume (2015 – 2020)

    The Top 5 Cancer Segments covered are:

     

    1.Lung Cancer

    2.Breast Cancer

    3.Colorectal Cancer

    4.Prostate Cancer

    5.Liver Cancer

     

    2. United States Liquid Biopsy Potential Treatment Monitoring Market & Test Volume (2015 – 2020)

    The Top 6 Cancer Segments covered are:

     

    1.Lung Cancer

    2.Breast Cancer

    3.Colorectal Cancer

    4.Prostate Cancer

    5.Liver Cancer

    6.Other Cancers

     

    Data Sources

    This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.

     

    Primary sources include industry surveys and telephone interviews with industry experts

     

    Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

    1.    Executive Summary

    2.    United States - Liquid Biopsy Potential Market (2015 – 2020) 
    2.1    United States - Liquid Biopsy Potential Market
    2.2    United States - Liquid Biopsy Screening Potential Market
    2.3    United States - Liquid Biopsy Treatment Monitoring Potential Market

    3.    United States - Liquid Biopsy Potential Test Volume (2015 – 2020) 
    3.1    United States - Liquid Biopsy Potential Test Volume
    3.2    United States - Liquid Biopsy Potential Screening Test Volume
    3.3    United States - Liquid Biopsy Potential Treatment Monitoring Test Volume

    4.    United States - Liquid Biopsy Potential Market Share (2015 – 2020) 
    4.1    United States - Liquid Biopsy Potential Market Share by Method
    4.2    United States - Liquid Biopsy Screening Potential Market Share by Cancer Types
    4.3    United States - Liquid Biopsy Treatment Monitoring Potential Market Share by Cancer Types

    5.    United States - Liquid Biopsy Potential Market & Test Volume by Cancer Types (2015 – 2020) 
    5.1    United States - Liquid Biopsy Lung Cancer Potential Market & Test Volume

    5.1.1    United States - Liquid Biopsy Lung Cancer Potential Market
    5.1.2    United States - Liquid Biopsy Lung Cancer Potential Test Volume

    5.2    United States - Liquid Biopsy Breast Cancer Potential Market & Test Volume
    5.2.1    United States - Liquid Biopsy Breast Cancer Potential Market
    5.2.2    United States - Liquid Biopsy Breast Cancer Potential Test Volume

    5.3    United States - Liquid Biopsy Colorectal Cancer Potential Market & Test Volume
    5.3.1    United States - Liquid Biopsy Colorectal Cancer Potential Market
    5.3.2    United States - Liquid Biopsy Colorectal Cancer Potential Test Volume

    5.4    United States - Liquid Biopsy Prostate Cancer Potential Market & Test Volume
    5.4.1    United States - Liquid Biopsy Prostate Cancer Potential Market
    5.4.2    United States - Liquid Biopsy Prostate Cancer Potential Test Volume

    5.5    United States - Liquid Biopsy Liver Cancer Potential Market & Test Volume
    5.5.1    United States - Liquid Biopsy Liver Cancer Potential Market
    5.5.2    United States - Liquid Biopsy Liver Cancer Potential Test Volume

    6.    United States - Liquid Biopsy Screening Potential Market & Test Volume by Cancer Types (2015 – 2020) 
    6.1    United States - Liquid Biopsy Lung Cancer Screening Potential Market & Test Volume
    6.1.1    United States - Liquid Biopsy Lung Cancer Screening Potential Market
    6.1.2    United States - Liquid Biopsy Lung Cancer Screening Potential Test Volume

    6.2    United States - Liquid Biopsy Breast Cancer Screening Potential Market & Test Volume
    6.2.1    United States - Liquid Biopsy Breast Cancer Screening Potential Market
    6.2.2    United States - Liquid Biopsy Breast Cancer Screening Potential Test Volume

    6.3    United States - Liquid Biopsy Colorectal Cancer Screening Potential Market & Test Volume
    6.3.1    United States - Liquid Biopsy Colorectal Cancer Screening Potential Market
    6.3.2    United States - Liquid Biopsy Colorectal Cancer Screening Potential Test Volume

    6.4    United States - Liquid Biopsy Prostate Cancer Screening Potential Market & Test Volume
    6.4.1    United States - Liquid Biopsy Prostate Cancer Screening Potential Market
    6.4.2    United States - Liquid Biopsy Prostate Cancer Screening Potential Test Volume

    6.5    United States - Liquid Biopsy Liver Cancer Screening Potential Market & Test Volume
    6.5.1    United States - Liquid Biopsy Liver Cancer Screening Potential Market
    6.5.2    United States - Liquid Biopsy Liver Cancer Screening Potential Test Volume

    7.    United States - Liquid Biopsy Treatment Monitoring Potential Market & Test Volume by Cancer Types (2015 – 2020) 
    7.1    United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market & Test Volume
    7.1.1    United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market
    7.1.2    United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Test Volume

    7.2    United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market & Test Volume
    7.2.1    United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market
    7.2.2    United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Test Volume

    7.3    United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market & Test Volume
    7.3.1    United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market
    7.3.2    United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Test Volume

    7.4    United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market & Test Volume
    7.4.1    United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market
    7.4.2    United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Test Volume

    7.5    United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market & Test Volume
    7.5.1    United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market
    7.5.2    United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Test Volume

    7.6    United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market & Test Volume
    7.6.1    United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market
    7.6.2    United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Test Volume

    8.    Liquid Biopsy Market – Recent Development

    9.    Liquid Biopsy Market – Major Deals Analysis

    10.    Liquid Biopsy Market – Driving Factors
    10.1    Real-Time Evaluation, Convenient and Accuracy
    10.2    Increasing Demand for Minimally-Invasive Biopsy Techniques
    10.3    Technical Advancement & Personalized Therapies 

    11.    Liquid Biopsy Market – Challenges
    11.1    Barriers for Liquid Biopsies
    11.1.1    Comparatively Low Concentration of Molecular Biomarkers in Body Fluids
    11.1.2    Low Concentration of Target DNA in A Plasma Sample
    11.1.3    Proper Handling and Storage of the Samples Critical

    List of Figures:

    Figure 2 1: United States - Liquid Biopsy Potential Market (Million US$), 2015 - 2020
    Figure 2 2: United States - Liquid Biopsy Screening Potential Market (Million US$), 2015 - 2020
    Figure 2 3: United States - Liquid Biopsy Treatment Monitoring Potential Market (Million US$), 2015 - 2020

    Figure 3 1: United States - Liquid Biopsy Potential Test Volume (Number), 2015 - 2020
    Figure 3 2: United States - Liquid Biopsy Potential Screening Test Volume (Number), 2015 - 2020
    Figure 3 3: United States - Liquid Biopsy Potential Treatment Monitoring Test Volume (Number), 2015 - 2020

    Figure 4 1: United States – Method Wise Liquid Biopsy Potential Market Share (Percent), 2015 - 2020
    Figure 4 2: United States - Liquid Biopsy Screening Potential Market Share by Cancer Types (Percent), 2015 - 2020
    Figure 4 3: United States - Liquid Biopsy Treatment Monitoring Potential Market Share by Cancer Types (Percent), 2015 - 2020

    Figure 5 1: United States - Liquid Biopsy Lung Cancer Potential Market (Million US$), 2015 - 2020
    Figure 5 2: United States - Liquid Biopsy Lung Cancer Potential Test Volume (Number), 2015 - 2020
    Figure 5 3: United States - Liquid Biopsy Breast Cancer Potential Market (Million US$), 2015 - 2020
    Figure 5 4: United States - Liquid Biopsy Breast Cancer Potential Test Volume (Number), 2015 - 2020
    Figure 5 5: United States - Liquid Biopsy Colorectal Cancer Potential Market (Million US$), 2015 - 2020
    Figure 5 6: United States - Liquid Biopsy Colorectal Cancer Potential Test Volume (Number), 2015 - 2020
    Figure 5 7: United States - Liquid Biopsy Prostate Cancer Potential Market (Million US$), 2015 - 2020
    Figure 5 8: United States - Liquid Biopsy Prostate Cancer Potential Test Volume (Number), 2015 - 2020
    Figure 5 9: United States - Liquid Biopsy Liver Cancer Potential Market (Million US$), 2015 - 2020
    Figure 5 10: United States - Liquid Biopsy Liver Cancer Potential Test Volume (Number), 2015 - 2020

    Figure 6 1: United States - Liquid Biopsy Lung Cancer Screening Potential Market (Million US$), 2015 - 2020
    Figure 6 2: United States - Liquid Biopsy Lung Cancer Screening Potential Test Volume (Number), 2015 - 2020
    Figure 6 3: United States - Liquid Biopsy Breast Cancer Screening Potential Market (Million US$), 2015 - 2020
    Figure 6 4: United States - Liquid Biopsy Breast Cancer Screening Potential Test Volume (Number), 2015 - 2020
    Figure 6 5: United States - Liquid Biopsy Colorectal Cancer Screening Potential Market (Million US$), 2015 - 2020
    Figure 6 6: United States - Liquid Biopsy Colorectal Cancer Screening Potential Test Volume (Number), 2015 - 2020
    Figure 6 7: United States - Liquid Biopsy Prostate Cancer Screening Potential Market (Million US$), 2015 - 2020
    Figure 6 8: United States - Liquid Biopsy Prostate Cancer Screening Potential Test Volume (Number), 2015 - 2020
    Figure 6 9: United States - Liquid Biopsy Liver Cancer Screening Potential Market (Million US$), 2015 - 2020
    Figure 6 10: United States - Liquid Biopsy Liver Cancer Screening Potential Test Volume (Number), 2015 – 2020

    Figure 7 1: United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market (Million US$), 2015 - 2020
    Figure 7 2: United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Test Volume (Number), 2015 - 2020
    Figure 7 3: United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market (Million US$), 2015 - 2020
    Figure 7 4: United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Test Volume (Number), 2015 - 2020
    Figure 7 5: United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market (Million US$), 2015 - 2020
    Figure 7 6: United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Test Volume (Number), 2015 - 2020
    Figure 7 7: United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market (Million US$), 2015 - 2020
    Figure 7 8: United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Test Volume (Number), 2015 - 2020
    Figure 7 9: United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market (Million US$), 2015 - 2020
    Figure 7 10: United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Test Volume (Number), 2015 - 2020
    Figure 7 11: United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market (Million US$), 2015 - 2020
    Figure 7 12: United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Test Volume (Number), 2015 - 2020

    • Description
      Price
    • Chapter 1 & 2     Pages : 7
      $200
    • Chapter 3     Pages : 5
      $175
    • Chapter 4     Pages : 3
      $200
    • Chapter 5     Pages : 13
      $300
    • Chapter 6     Pages : 10
      $300
    • Chapter 7     Pages : 15
      $300
    • Chapter 8 & 9     Pages : 7
      $150
    • Chapter 10 & 11     Pages : 5
      $150

    Related Products

    • United States - Biopsy Testing Market & Volume Analysis to 2020


      United States - Biopsy Testing Market & Volume Analysis to 2020
      United States Biopsy Test Market was more than US$ 15 Billion in 2014 and future seems to be much brighter. In the United States Biopsy Test Market, Breast Cancer is the most popular segment in 2014. Thyroid cancer stands at the last spot, but it is the most rapidly increasing type of cancer in the ...
      Date: 12 Jan, 2016
      Type: Diagnostics
      Pages: 53
      Price: $800.00
    • Global Non Invasive Prenatal Testing Market, Test Volume & Forecast


      Global Non Invasive Prenatal Testing Market, Test Volume & Forecast
      The development of the non-invasive prenatal test (NIPT) has transformed the prenatal testing market. NIPT has the potential to drastically change how pregnancies are managed. Non-invasive prenatal genetic testing (NIPT) has been commercially available since 2011 and has been rapidly adopted in the ...
      Date: 27 Oct, 2014
      Type: Life Science
      Pages: 67
      Price: $1,400.00